Clarity in cell line development

Duncan Borthwick joins Solentim as Global Marketing Manager

Solentim, the leader in cell line development (CLD) instrumentation, is pleased to announce that Dr Duncan Borthwick will join the Company as the new Global Marketing Manager. Duncan has a strong commercial background in bringing new technologies to international markets. With a PhD from Edinburgh University, his previous work experience includes life science distribution companies …

Read more Duncan Borthwick joins Solentim as Global Marketing Manager

Solentim are Recruiting | Global Head of Service

Company Information: About Solentim Solentim is a Life Sciences company committed to transforming the discovery and development of new biologics, to get materials into the clinic faster and to drive better outcomes for patients. As the global leader in accelerating cell line development through intelligent automation, we create practical solutions to speed up workflows. For …

Read more Solentim are Recruiting | Global Head of Service

The Challenges & Demands when Establishing a New Cell Line Development Lab

Ian Taylor will share his expertise on purchasing the right platform solution at SLAS 2020 Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be presenting and exhibiting at SLAS 2020, taking place 25-29 January, San Diego. The event showcases the latest cutting-edge developments in laboratory automation and screening, …

Read more The Challenges & Demands when Establishing a New Cell Line Development Lab

Clonal Derivation in Biopharmaceutical Cell Line Development – a Regulatory Perspective

19th November 2019: Early last month saw publication of the latest perspectives from the FDA in a paper entitled: Considering “clonality”: A regulatory perspective on the importance of the clonal derivation of mammalian cell banks in biopharmaceutical development authored by Joel Welch and Sarah Arden (USFDA). Key Points As a major supplier of technologies for …

Read more Clonal Derivation in Biopharmaceutical Cell Line Development – a Regulatory Perspective